The clinical investigation of psychedelic medicines has blossomed over the last 5 years.
Data from a Phase 3 industry trial and a multicenter Phase 2 industry trial, in addition to …

The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

Introduction Ayahuasca is a plant-based decoction native to Amazonia, where it has a long
history of use in traditional medicine. Contemporary ritual use of ayahuasca has been …

The therapeutic potential of the psychedelic brew ayahuasca has been investigated in
preclinical and clinical studies. Currently, the most consistent evidence refers to depression …

Background: Naturalistic and placebo-controlled studies suggest ayahuasca, a potent
psychedelic beverage originating from Indigenous Amazonian tradition, may improve mental …

Background There is growing scientific evidence for the therapeutic benefits of the
Amazonian plant-based psychedelic “ayahuasca” for neuropsychiatric disorders such as …

Background: Naturalistic and placebo-controlled studies have suggested that ayahuasca, a
traditional Amazonian beverage, could be helpful in the treatment of psychopathologies like …

Ayahuasca is a traditional plant decoction containing N, N-dimethyltryptamine (DMT) and
various β-carbolines including harmine, harmaline, and tetrahydroharmine, which has been …

The potent hallucinogen N, N-dimethyltryptamine (DMT) has garnered significant interest in
recent years due to its profound effects on consciousness and its therapeutic …

Ayahuasca is a psychoactive Amazonian plant brew. It is usually made from the
Banisteriopsis caapi vine (Spruce ex Griseb. Morton, Malpighiaceae), which contains three …